Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Free Report) – Equities researchers at Capital One Financial increased their FY2023 EPS estimates for Olema Pharmaceuticals in a research report issued to clients and investors on Monday, November 13th. Capital One Financial analyst Z. Jallah now anticipates that the company will post earnings per share of ($2.22) for the […]
Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) traded up 8.3% during trading on Wednesday . The company traded as high as $17.20 and last traded at $17.20. 34,407 shares changed hands during trading, a decline of 88% from the average session volume of 288,567 shares. The stock had previously closed at $15.88. […]
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) fell 4.9% during trading on Monday . The company traded as low as $15.01 and last traded at $15.06. 209,613 shares were traded during trading, a decline of 27% from the average session volume of 285,469 shares. The stock had previously closed at $15.83. Analyst Ratings Changes […]
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) Director Cyrus Harmon sold 5,000 shares of Olema Pharmaceuticals stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $15.64, for a total transaction of $78,200.00. Following the transaction, the director now directly owns 943,714 shares of the […]
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) has earned a consensus rating of “Buy” from the six ratings firms that are currently covering the firm, MarketBeat.com reports. Six investment analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have updated their coverage on the stock in […]